Roberto serves on the R&D leadership team at Ridgeline Therapeutics, Versant's Basel-based Discovery Engine. He is responsible for sourcing and evaluating academic opportunities from European institutes, and for leading biology and translational activities for Ridgeline NewCos.
Roberto brings over 8 years of industry experience in preclinical research at Roche, having managed discovery programs across a range of therapeutic areas including Neuroscience, Ophthalmology and Cardiometabolics. He most recently served as Roche's Head of Rare Diseases Research, and established numerous external collaborations with academic and biotech partners. Roberto holds an M.D. from the University of Napoli, a Ph.D. from the Max Planck Research School for Molecular Cell Biology and Genetics, and did his post-doc research at NIBR in Basel.